|Day's Range||5.83 - 5.84|
|52 Week Range||3.25 - 7.10|
|PE Ratio (TTM)||-6.65|
|Earnings Date||May 12, 2017 - May 15, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||7.45|
NEW YORK, NY / ACCESSWIRE / July 17, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
NASDAQ: CRME TSX: COM VANCOUVER , July 17, 2017 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM) today announced that the Therapeutic Products Directorate (TPD) of Health Canada has approved ...
Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen